HEKTOEN INSTITUTE FOR MEDICAL RESEARCH

Chicago, IL

OncologymicrobiomeGrant-only

Compare Sign in to watch

What changed

NIH K99 · $0.2M · Building evidence for effective extended-release buprenorphine treatment for opioid use disorder

Jun 2025New grantJun 26, 2025Source filing (opens the source filing in a new tab)

Momentum

58no change

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

9,941 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
K99 · $202k · non-dilutive
Jul 1, 2025
UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ROSS, RACHAEL KENDRA · NIDA · award ends Jun 30, 2027 · Building evidence for effective extended-release buprenorphine treatment for opioid use disorder
NIH RePORTER · NIH RePORTER 11229434 (opens the source filing in a new tab)
Grant
R01 · $493k · non-dilutive
Feb 1, 2025
MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROSS, RYAN · NICHD · award ends Jan 31, 2030 · Modified cardiac rehabilitation to enhance post-stroke physical and psychosocial function: does despression limit the response?
NIH RePORTER · NIH RePORTER 11049465 (opens the source filing in a new tab)
Grant
R21 · $630k · non-dilutive
Feb 1, 2025
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FUCHS, SEBASTIAN PATRICK · OD · award ends Jan 31, 2027 · Immunomodulatory drug interventions for the prevention of host immune responses toward AAV-delivered anti-HIV antibodies
NIH RePORTER · NIH RePORTER 11085522 (opens the source filing in a new tab)
Grant
R01 · $674k · non-dilutive
Mar 5, 2024
PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SPIEGELMAN, VLADIMIR S. · NCI · award ends Feb 28, 2029 · Targeting ß-TrCP regulators to improve CRC response to chemotherapy
NIH RePORTER · NIH RePORTER 11049159 (opens the source filing in a new tab)
Grant
R01 · $509k · non-dilutive
Feb 1, 2024
UNIVERSITY OF PENNSYLVANIA · PI FUCHS, SERGE Y · NCI · award ends Jan 31, 2029 · Targeting immunosuppression of intratumoral CAR T cells
NIH RePORTER · NIH RePORTER 11014461 (opens the source filing in a new tab)
Trial
NA registered
Sep 30, 2022
Exercise, Cardiorespiratory Fitness · RECRUITING · sponsor: Robert Ross, PhD · Response Variability to Exercise
ClinicalTrials.gov · NCT05496751 (opens the source filing in a new tab)
Grant
R01 · $718k · non-dilutive
Jul 18, 2022
UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSS, ROBERT SCOTT · NHLBI · award ends Apr 30, 2027 · Cardiac Myocyte Protein Partners in Heart Function
NIH RePORTER · NIH RePORTER 11076252 (opens the source filing in a new tab)
Grant
IK2 · non-dilutive
Feb 1, 2021
RALPH H JOHNSON VA MEDICAL CENTER · PI ROSS, RYAN · VA · award ends Jan 31, 2027 · Priming the Rehabilitation Engine: Aerobic Exercise as the Fuel to Spark Behavioral Improvements in Stroke
NIH RePORTER · NIH RePORTER 11056687 (opens the source filing in a new tab)
Grant
U01 · $3.0M · non-dilutive
Apr 1, 2019
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI FRENCH, AUDREY · NHLBI · award ends Sep 30, 2026 · MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS)
NIH RePORTER · NIH RePORTER 11092283 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75principal investigator ROSS, RYAN is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75principal investigator FUCHS, SEBASTIAN PATRICK is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.24same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH K99 · $0.2M · Building evidence for effective extended-release buprenorphine treatment for opioid use disorder
Jun 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Cardiac Myocyte Protein Partners in Heart Function
Apr 2025Grant renewalSource (opens the source filing in a new tab)
NIH IK2 · Priming the Rehabilitation Engine: Aerobic Exercise as the Fuel to Spark Behavioral Improvements in Stroke
Apr 2025Grant renewalSource (opens the source filing in a new tab)
NIH U01 · $3.0M · MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS)
Mar 2025Grant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Response Variability to Exercise
Mar 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Response Variability to Exercise
Mar 2025Trial recruitingSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Targeting ß-TrCP regulators to improve CRC response to chemotherapy
Feb 2025Grant renewalSource (opens the source filing in a new tab)
NIH R21 · $0.6M · Immunomodulatory drug interventions for the prevention of host immune responses toward AAV-delivered anti-HIV antibodies
Jan 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Modified cardiac rehabilitation to enhance post-stroke physical and psychosocial function: does despression limit the response?
Jan 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Targeting immunosuppression of intratumoral CAR T cells
Jan 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

K99 · $202k · non-dilutive

R01 · $493k · non-dilutive

R21 · $630k · non-dilutive

R01 · $674k · non-dilutive

R01 · $509k · non-dilutive

NA registered

R01 · $718k · non-dilutive

IK2 · non-dilutive

U01 · $3.0M · non-dilutive